allylamine has been researched along with Cardiovascular Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Esan, O; Viljoen, A; Wierzbicki, AS | 1 |
| Garg, SK; Michels, AW; Shah, VN | 1 |
| Marrs, JC | 1 |
| Abby, SL; Jialal, I; Misir, S; Nagendran, S | 1 |
| Bell, DS; O'Keefe, JH | 1 |
| Wright, WL | 1 |
| Fonseca, VA; Handelsman, Y; Staels, B | 1 |
| Jellinger, PS; Levy, P | 1 |
| Hagan, MA; Simons, WR | 1 |
| Ganda, OP | 1 |
| Wilkinson, E | 1 |
| Boudes, P; Viereck, C | 1 |
| Boor, PJ; Conklin, DJ; Trent, MB | 1 |
| Cox, LR; Grossman, SL; Ramos, K | 1 |
| Boor, PJ; Hysmith, RM | 1 |
| Boor, PJ; Hysmith, RH; Welch, TK | 1 |
6 review(s) available for allylamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Use of non-insulin therapies for type 1 diabetes.
Topics: Allylamine; Animals; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Gastrins; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Islet Amyloid Polypeptide; Leptin; Metformin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; United States | 2013 |
Colesevelam for the management of type 2 diabetes.
Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Cholesterol; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Humans; Hyperglycemia | 2009 |
Rediscovering bile acid sequestrants.
Topics: Allylamine; Anticholesteremic Agents; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fluorobenzenes; Humans; Hypoglycemic Agents; Primary Prevention; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2009 |
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence.
Topics: Adult; Allylamine; Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Lipids; Male | 2010 |
The potential role of colesevelam in the management of prediabetes and type 2 diabetes mellitus.
Topics: Administration, Oral; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Practice Guidelines as Topic; Prediabetic State; Prognosis; Severity of Illness Index; Treatment Outcome | 2010 |
The role of bile acid sequestrants in the management of type 2 diabetes mellitus.
Topics: Adult; Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cardiovascular Diseases; Clinical Trials as Topic; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Humans | 2010 |
1 trial(s) available for allylamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Topics: Aged; Allylamine; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Sulfonylurea Compounds | 2009 |
10 other study(ies) available for allylamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Triglycerides | 2022 |
What role for [black triangle down] colesevelam in cardiovascular prevention?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Colesevelam Hydrochloride; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Treatment Outcome | 2009 |
The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
Topics: Allylamine; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Disease Progression; Drug Monitoring; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Life Style; Practice Guidelines as Topic; Risk Reduction Behavior; Treatment Outcome; United States | 2009 |
An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Topics: Adult; Aged; Allylamine; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Cost-Benefit Analysis; Databases, Factual; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Health Care Costs; Humans; Hypercholesterolemia; Insulin; Male; Metformin; Middle Aged; Models, Economic; Randomized Controlled Trials as Topic; Risk; Sulfonylurea Compounds; Treatment Outcome; United States | 2010 |
Genzyme's research in cardiovascular disease, putting rare conditions on centre stage.
Topics: Allylamine; Anticholesteremic Agents; Cardiovascular Diseases; Colesevelam Hydrochloride; Drug Industry; Humans; Hyperlipoproteinemia Type II; Rare Diseases | 2010 |
An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development.
Topics: Adamantane; Allylamine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin; Investigational New Drug Application; Liraglutide; Nitriles; Peptides; Piperidines; Practice Guidelines as Topic; Pyrazines; Pyrrolidines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Time Factors; Triazoles; United States; United States Food and Drug Administration; Uracil; Venoms; Vildagliptin | 2011 |
The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
Topics: Allylamine; Amine Oxidase (Copper-Containing); Aminopropionitrile; Animals; Aorta; Cardiovascular Diseases; Cell Survival; Cells, Cultured; Drinking; Enzyme Inhibitors; Hemodynamics; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Rats; Rats, Sprague-Dawley | 1999 |
Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
Topics: Acrolein; Aldehydes; Allylamine; Amines; Animals; Benzylamine Oxidase; Cardiovascular Diseases; Cells, Cultured; Clorgyline; Ditiocarb; Endothelium, Vascular; Hydrogen Peroxide; L-Lactate Dehydrogenase; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Muscle, Smooth, Vascular; Pargyline; Rats; Rats, Inbred Strains; Semicarbazides | 1988 |
Allylamine cardiovascular toxicity.
Topics: Allylamine; Amines; Animals; Cardiovascular Diseases; Environmental Exposure; History, 20th Century; Humans; In Vitro Techniques; Monoamine Oxidase Inhibitors | 1987 |
The comparative study of cardiovascular toxins utilizing a sensitive indicator of sublethal toxic injury.
Topics: Allylamine; Amines; Aminopropionitrile; Animals; Aorta, Thoracic; Cardiovascular Diseases; Isoproterenol; Kinetics; Male; Muscle, Smooth, Vascular; Swine; Uridine | 1987 |